Funding for this research was provided by:
Received: 4 July 2019
Accepted: 27 November 2019
First Online: 12 December 2019
Ethics approval and consent to participate
: This study was approved by the Ethics committee of the University Medical Center Göttingen. Since this study is a retrospective analysis that comprises anonymized data, informed consent was not required. All methods were carried out in accordance with the relevant guidelines and regulations.
: Not applicable.
: JW received honoraria for Consulting Activities, Lectures or Advisory Board participation from Pfizer, Eli Lilly, Hoffmann-La-Roche, MSD Sharp & Dome, Janssen-Cilag GmbH, Immungenetics AG, Boehringer Ingelheim. Patents/Royalties: Patent no.: EP1270592B1; patent no.: US 6.849.416 B2; patent no.: EP2095128B1; patent no.: EP3105589A1.In the past 3 years, BB has been on the speakers’ board for Hexal, Janssen, Lilly and Lundbeck and on the Advisory board for Mundipharma and Lundbeck and has received publication honoraria from Servier.Over the past two years, DW has been on the speakers’ board for Servier.CT, MM, KRE, AMP declare that they have no conflict of interest.